Neurobiogen Co Ltd. has synthesized monoamine oxidase-B (MAO-B) inhibitors reported to be useful for the treatment of Parkinson’s disease.

Shih, Heinz-Josef Lenz. Monoamine oxidase B: a potential therapeutic target for colorectal cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part ...

Despite the replacement of the monoamine hypothesis of depression with a more comprehensive understanding of multiple influencing factors in the pathology of depression, it is clear that elevating ...

Metoprolol can interact with several medications, including certain blood pressure drugs, monoamine oxidase inhibitors (MAOIs), digoxin, and others. Metoprolol is a commonly prescribed beta-blocker ...

What Are Monoamine Oxidase Inhibitors? Monoamine oxidase inhibitors (MAOIs) are an extremely strong class of antidepressants that treat depression by preventing the breakdown of the brain ...

CALGARY, Alberta, Aug. 29, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage ...

They may also be used off-label for: MAOI antidepressants work by blocking the effects of the enzyme monoamine oxidase in your brain. Monoamine oxidase is a protein that breaks down the brain ...